Novel Coronavirus (SARS-CoV-2/COVID-19)
Jim Skogsbergh, president and CEO of Advocate Aurora Health, will join AHA Board Chair Melinda Estes, M.D., Oct. 22 at 3:30 p.m. ET to discuss COVID-19’s impact on health trends and key strategies for reimagining and innovating care during and beyond the pandemic.
Hear several organizations describe their programs to address patients' unmet legal needs and how COVID-19 has shaped the focus of medical-legal partnerships.
COVID-19 is a pandemic with no precedent, and certainly no equal. In many ways, we’ve been learning as we go. For health care professionals, this has elevated the importance of peer-to-peer sharing as never before.
A recent article on hospital field finances ignores the diverse experiences of hospitals during the pandemic, particularly those under significant financial pressure, writes Aaron Wesolowski, AHA’s vice president of policy research, analytics and strategy.
The National Institutes of Health announced the start of an adaptive phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.
The Food and Drug Administration Oct. 15 removed epinephrine from the lists of drugs authorized for temporary compounding during the COVID-19 public health emergency by outsourcing facilities and state-licensed pharmacies or federal facilities not registered as outsourcing facilities.
The Food and Drug Administration Oct. 15 said it reissued its emergency use authorization for certain, Chinese-manufactured filtering face-piece respirators that lack National Institute for Occupational Safety and Health approval.
The Centers for Medicare & Medicaid Services Oct. 15 said it will incentivize labs to deliver quicker results to patients undergoing COVID-19 diagnostic testing.
The Department of Health and Human Services announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to long-term care facility residents.
Join AHA Board Chair Melinda Estes, M.D., for the seventh in a series of Leadership Rounds — short conversations on a range of key issues Dr. Estes will have with hospital and health system leaders from across the country. Dr. Estes will joined by Jim Skogsbergh, President and CEO of Advocate…